EFSA publishes Geographical BSE-Risk (GBR) assessments for Australia, Canada, Mexico, Norway, South Africa, Sweden and the United States of America
In 2003 EFSA was requested by the European Commission (EC) to re-assess the Geographical Bovine Spongiform Encephalopathy (BSE) risk (GBR) for 13 countries: Australia, Botswana, Canada, Costa Rica, El Salvador, Nicaragua, Namibia, Norway, Mexico, Panama, Swaziland, Sweden and the United States. Although the European Commission did not specifically seek advice from EFSA relating to the appearance of BSE in South Africa, the working group decided to carry out a risk assessment for this country under a self-tasking mandate in order to allow for a meaningful evaluation of the three other countries in the Southern African Region for which a GBR assessment was requested (i.e. Botswana, Namibia, Swaziland). EFSA’s Scientific Expert Working Group on the Assessment of the GBR has completed to date those assessments relating to Australia, Canada, Mexico, Norway, South Africa, Sweden and the United States of America. The GBR assessments for the remaining countries will be finalized by the end of 2004.
In conducting the GBR assessments, EFSA’s GBR working group followed the methodology developed by the former Scientific Steering Committee of DG Health and Consumer Safety (DG SANCO) of the European Commission which is described in its final opinion on GBR assessment . The risk assessments published today are based on up-to-date data provided by the countries concerned as well as other sources of data (i.e. Eurostat and country export data) covering the period of 1980 to 2003.
GBR level | Presence of one or more cattle clinically or pre-clinically infected with the BSE agent in a geographical region/country | GBR of the country/Region Current status (status before) |
I | Highly unlikely | Australia (I) |
II | Unlikely but not excluded | Norway (I), Sweden (II) |
III | Likely but not confirmed or confirmed at a lower level | Canada (II), Mexico (N/A), South Africa (N/A), USA (II) |
IV | Confirmed at a higher level |
N/A= not applicable, i.e. not assessed before
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
